EGFR and esophageal squamous cell carcinoma: Based on these results, we note that 64Cu-PCTA-cetuximab immuno-PET imaging may be useful for evaluating the level of EGFR expression on ESCC tumors in vitro and in vivo and determining change of EGFR expression with cetuximab treatment.